February 6, 2025
EMBO-02 Assesses NeoCast™ for the Treatment of Chronic Subdural Hematoma
News
February 5, 2025
Next-Generation Liquid Embolic, NeoCast™, Successfully Occludes Distal Middle Meningeal Artery
Branches of Chronic Subdural Hematoma Patients in Initial Cohort of First-In-Human Study
Branches of Chronic Subdural Hematoma Patients in Initial Cohort of First-In-Human Study
November 14, 2024
Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma
First Patient Enrolled in Trial to Evaluate Safety and Feasibility of Innovative Embolic Agent in Expanded Patient Population Utilizing Middle Meningeal Artery Embolization (MMAe)
